Association between genotypic and phenotypic pyrazinamide resistance in Mycobacterium tuberculosis

被引：1
|
作者：
Whitfield, M. G. [1 ]
Streicher, E. M. [1 ]
York, T. [1 ]
Mardarowicz, I. [1 ]
Scott, L. [2 ]
Stevens, W. [2 ]
van Helden, P. D. [1 ]
Warren, R. M. [1 ]
Van Rie, A. [3 ]
机构：
[1] Univ Stellenbosch, ZA-7505 Tygerberg, South Africa
[2] Natl Hlth Lab Serv, Johannesburg, South Africa
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2014年 / 21卷
关键词：
D O I：
10.1016/j.ijid.2014.03.628
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
40.038
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [31] Characterization of phenotypic and genotypic drug resistance patterns of Mycobacterium tuberculosis isolates from a city in Mexico
    Flores-Trevino, Samantha
    Morfin-Otero, Rayo
    Rodriguez-Noriega, Eduardo
    Gonzalez-Diaz, Esteban
    Raul Perez-Gomez, Hector
    Mendoza-Olazaran, Soraya
    Balderas-Renteria, Isaias
    Maria Gonzalez, Gloria
    Garza-Gonzalez, Elvira
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (03): : 181 - 185
  • [32] Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance
    Alame-Emane, A. K.
    Xu, P.
    Pierre-Audigier, C.
    Cadet-Daniel, V.
    Shen, X.
    Sraouia, M.
    Siawaya, J. F. Djoba
    Takiff, H.
    Gao, Q.
    Gicquel, B.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (06) : 679 - 684
  • [33] Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance
    Shrestha, Dipti
    Maharjan, Bhagwan
    Thapa, Jeewan
    Akapelwa, Mwangala Lonah
    Bwalya, Precious
    Chizimu, Joseph Yamweka
    Nakajima, Chie
    Suzuki, Yasuhiko
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (09) : 4132 - 4141
  • [34] Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate
    Hu, Y.
    Wu, X.
    Luo, J.
    Fu, Y.
    Zhao, L.
    Ma, Y.
    Li, Y.
    Liang, Q.
    Shang, Y.
    Huang, H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (11) : 835 - 838
  • [35] The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
    Akos Somoskovi
    Linda M Parsons
    Max Salfinger
    Respiratory Research, 2
  • [36] Determination of drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide
    A. V. Nizova
    V. N. Stepanshina
    N. V. Maiskaya
    R. I. Mironova
    A. G. Bogun
    I. V. Domotenko
    T. P. Morozova
    I. G. Shemyakin
    Molecular Genetics, Microbiology and Virology, 2008, 23 : 184 - 188
  • [37] PncAgene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
    Katherine Lozano Untiveros
    Patricia Sheen
    BMC Proceedings, 8 (Suppl 4)
  • [38] Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
    Hirano, K
    Takahashi, M
    Kazumi, Y
    Fukasawa, Y
    Abe, C
    TUBERCLE AND LUNG DISEASE, 1998, 78 (02): : 117 - 122
  • [39] Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
    Che, Yang
    Bo, Dingyi
    Lin, Xiang
    Chen, Tong
    He, Tianfeng
    Lin, Yi
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [40] Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
    Yang Che
    Dingyi Bo
    Xiang Lin
    Tong Chen
    Tianfeng He
    Yi Lin
    BMC Infectious Diseases, 21
12345